Frontiers | Mortality Rate of Lymphoma in China, 2013–2020
Overall survival of patients with non-Hodgkin's lymphoma receiving... | Download Scientific Diagram
Lymphoma | Radiology Key
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission | Journal of Clinical Oncology
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
Epidemiology and Determinants of Survival for Primary Intestinal Non-Hodgkin's Lymphoma – A Population Based Study | medRxiv
Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma | Signal Transduction and Targeted Therapy
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
Non-Hodgkin Lymphoma of the Liver: A US Population-based Analysis
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Overall survival curve of 48 patients with mantle cell lymphoma... | Download Scientific Diagram
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect
Cancers | Free Full-Text | Treatment and Outcome Analysis of 639 Relapsed Non-Hodgkin Lymphomas in Children and Adolescents and Resulting Treatment Recommendations
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology
Cancers | Free Full-Text | Immunosuppressive Microenvironment and Efficacy of PD-1 Inhibitors in Relapsed/Refractory Classic Hodgkin Lymphoma: Checkpoint Molecules Landscape and Macrophage Populations